All systems operational
Q1 2025

Design, synthesis, biological evaluation and in silico studies of 2-anilino- 4-(benzimidazol- 1-yl)pyrimidine scaffold as antitumor agents

Lamees S. Al-Rasheed · Siddique Akber Ansari · Hanadi H. Asiri · Ahmed H. Bakheit · Abdulrahman A. Al-mehizia · Amsha S. Alsegiani · Hamad M. Alkahtani
10.1007/s44446-025-00010-w 414 Views 2 Citations
2
Citations
414
Views
Abstract not available for this publication.
Cite this Article (APA)
Lamees, S. A., Siddique, A. A., Hanadi, H. A., Ahmed, H. B., Abdulrahman, A. A., Amsha, S. A., Hamad, M. A. (2025). Design, synthesis, biological evaluation and in silico studies of 2-anilino- 4-(benzimidazol- 1-yl)pyrimidine scaffold as antitumor agents. Saudi Pharmaceutical Journal. https://doi.org/10.1007/s44446-025-00010-w
Related Papers
Human plasma derived exosomes: Impact of active and passive drug loading approaches on drug delivery
Rabia Gul; Hamid Bashir; Muhammad Sarfraz; Ahson Jabbar Shaikh; Yousef A. Bin Ja · 2024
40
cites
433
Rise of implantable drugs: A chronicle of breakthroughs in drug delivery systems
Kampanart Huanbutta; Vivek Puri; Ameya Sharma; Inderbir Singh; Pornsak Sriamorns · 2024
30
cites
483
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities
Hussain A. Al-Omar; Ali Alshehri; Saleh A. Alqahtani; Hana Alabdulkarim; Ali Alr · 2024
26
cites
514
Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management …
Faisal Imam; Sayantan Mukhopadhyay; Preeti Kothiyal; Samiyah Alshehri; Khalid Sa · 2024
24
cites
537
Access
View Full Text via DOI
Published in
ISSN 1319-0164
Quartile Q1
AMS Score 100
Field Medicine & Health Sciences
Publisher Elsevier / Saudi Pharmaceutical Soc
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2025
Language English
Added 23 Jul 2026